Paperplane therapeutic agents Has collected 1.5 million US dollars to treat patients for pain and fear using a virtual reality and possibly travel to the dentist more pleasantly.
The company based in Montreal, Canada, specializes in therapeutic virtual reality solutions for pain and fear management in healthcare.
Glen Ventures led the round with financial support from the Du Québec governorate via investment québec. Strategic investors such as Cabhi (Center for Aging + Brain Health Innovation), Cedars-Sinai company, Angel Québec and Aventure Capital also took part.
Pain and anxiety are causing important obstacles for patients who are looking for medical care that often lead to delays, increased symptoms and more complex treatments. This problem is particularly widespread in dentistry, in which approximately 36% of people are afraid of visits to dental visits, 12% suffer from extreme dentistry tangness, and 22% shift the appointments until the pain forces you to take care of care, what to do increased costs and complications.
In this sense, Paperplanes focus on the North American dentist market and would like to improve the patient experiences and clinical workflows with its therapeutic virtual reality solutions.
Paperplane’s technology deals with this challenge by viewing dental procedures – often considered painful and traumatic – by haunting virtual reality more manageable and even more pleasant experiences.
Paperplane’s solutions for patients of all ages develop a special focus on pediatric care. Paperplan also shines clinical work processes and reduces the burden for clinicians.
“As an emergency doctor, I saw the lack of options for the treatment of pain and fear first-hand,” said Jean-Simon Fortin, CEO of Paperplane Therapeutics, in an explanation. “Today I am proud that our VR technology fills this gap and that members of the health professions offer a more effective opportunity to support their patients. This financing enables us to expand our reach and to really provide even more clinicians transformatively. “
This financing marks a significant milestone in the growth of paperplane and enables the company to continue its mission, to use virtual reality therapies in the dentist circle and to improve both the results of the patients and the care in North America. In addition, this investment will support the expansion of paperplane in Europe with a strategic partnership with the French company Hypnovr, which is supported by its CE marketing.
Michael Goodman, founding partner at Glen Ventures, said in a statement: “Paperplan redefines how we approach pain and fear management in healthcare. Your VR solutions not only improve patient comfort, but also contribute to more efficient clinical work processes. We are proud to support a company that increases the standard of patient care and at the same time exceeds the limits of medical innovation. “
Christopher Skeet, Quebec’s Minister of the Economy and Minister, who is responsible for the fight against racism, said in a statement: “Quebec’s ingenuity has the authority to shape the future of our health system, and Paperplane therapeutic drugs is a first -class example. Our government is proud to support the development of solutions that improve both the quality and the accessibility of patient care. “
“Paperplane therapeutics helps with the positioning of quebec as a leader in medical technology innovation through its virtual reality solutions,” added Bicha Ngo, CEO of Investissement Québec. “By rethinking the patient experience, the company demonstrates the immense potential of Quebec’s health innovations. With this investment, you now have the resources to speed up your growth. “
So far, the company has collected dilutive financing of $ 1 million and not dilutive funds of $ 1 million. The company has seven people. The company was founded in 2019, but the co-founders started working together with F&- and clinical studies in 2014.
In terms of inspiration, Fortin carried out a research project for the use of VR to manage pain and anxiety. Inspired by the results, he teamed up with David Paquin, an expert in creation and new media. Together with university students, they developed their first VR solution for children who need painful changes in Sainte-Justine Children’s Hospital. Encouraged by the success of these early studies, she established 2019 paper tarpaulin therapeutic agents to commercialize and expand these transformative VR therapies
Source link
